C. Chizzolini, Update on pathophysiology of scleroderma with special reference to immunoinflammatory events, Annals of Medicine, vol.64, issue.1, pp.42-53, 2007.
DOI : 10.1136/ard.2003.011205

Y. Allanore, P. Dieude, and C. Boileau, Genetic background of systemic sclerosis: autoimmune genes take centre stage, Rheumatology, vol.49, issue.2, pp.203-210, 2010.
DOI : 10.1093/rheumatology/kep368

R. Prescott, A. Freemont, C. Jones, J. Hoyland, and P. Fielding, Sequential dermal microvascular and perivascular changes in the development of scleroderma, The Journal of Pathology, vol.178, issue.3, pp.255-263, 1992.
DOI : 10.1002/path.1711660307

A. Kalogerou, E. Gelou, S. Mountantonakis, L. Settas, and E. Zafiriou, Early T cell activation in the skin from patients with systemic sclerosis, Annals of the Rheumatic Diseases, vol.64, issue.8, pp.1233-1235, 2005.
DOI : 10.1136/ard.2004.027094

K. Scharffetter, B. Lankat-buttgereit, and T. Krieg, Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization, European Journal of Clinical Investigation, vol.23, issue.1, pp.9-17, 1988.
DOI : 10.1007/BF00403930

S. Allen, S. Crown, and T. Handel, Chemokine:Receptor Structure, Interactions, and Antagonism, Annual Review of Immunology, vol.25, issue.1, pp.787-820, 2007.
DOI : 10.1146/annurev.immunol.24.021605.090529

S. Bromley, T. Mempel, and A. Luster, Orchestrating the orchestrators: chemokines in control of T cell traffic, Nature Immunology, vol.6, issue.9, pp.970-980, 2008.
DOI : 10.1038/ni.f.213

J. Campbell, O. Connell, D. Wurbel, and M. , Cutting Edge: Chemokine Receptor CCR4 Is Necessary for Antigen-Driven Cutaneous Accumulation of CD4 T Cells under Physiological Conditions, The Journal of Immunology, vol.178, issue.6, pp.3358-3362, 2007.
DOI : 10.4049/jimmunol.178.6.3358

D. Soler, T. Humphreys, S. Spinola, and J. Campbell, CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking, Blood, vol.101, issue.5, pp.1677-1682, 2003.
DOI : 10.1182/blood-2002-07-2348

Y. Reiss, A. Proudfoot, C. Power, J. Campbell, and E. Butcher, CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell???attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin, The Journal of Experimental Medicine, vol.144, issue.10, pp.1541-1547, 2001.
DOI : 10.1084/jem.193.9.1105

D. Fitzhugh, S. Naik, S. Caughman, and S. Hwang, Cutting Edge: C-C Chemokine Receptor 6 Is Essential for Arrest of a Subset of Memory T Cells on Activated Dermal Microvascular Endothelial Cells Under Physiologic Flow Conditions In Vitro, The Journal of Immunology, vol.165, issue.12, pp.6677-6681, 2000.
DOI : 10.4049/jimmunol.165.12.6677

S. Singh, H. Zhang, J. Foley, M. Hedrick, and J. Farber, Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6, The Journal of Immunology, vol.180, issue.1, pp.214-221, 2008.
DOI : 10.4049/jimmunol.180.1.214

F. Annunziato and S. Romagnani, Heterogeneity of human effector CD4+ T cells, Arthritis Research & Therapy, vol.11, issue.6, p.257, 2009.
DOI : 10.1186/ar2843

J. Zhu and W. Paul, Heterogeneity and plasticity of T helper cells, Cell Research, vol.180, issue.1, pp.4-12, 2010.
DOI : 10.1038/ni.1730

C. Kim, L. Rott, E. Kunkel, M. Genovese, D. Andrew et al., Rules of chemokine receptor association with T cell polarization in vivo, Journal of Clinical Investigation, vol.108, issue.9, pp.1331-1339, 2001.
DOI : 10.1172/JCI13543

T. Duhen, R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, Nature Immunology, vol.123, issue.8, pp.857-863, 2009.
DOI : 10.1038/ni.1767

S. Trifari, C. Kaplan, E. Tran, N. Crellin, and H. Spits, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from, and T(H)2 cells, pp.864-871, 2009.

L. Cosmi, F. Annunziato, E. Maggi, S. Romagnani, and R. Manetti, Chemoattractant Receptors Expressed on Type 2 T Cells and Their Role in Disease, International Archives of Allergy and Immunology, vol.125, issue.4, pp.273-279, 2001.
DOI : 10.1159/000053827

L. Cosmi, D. Palma, R. Santarlasci, V. Maggi, L. Capone et al., T cell precursor, The Journal of Experimental Medicine, vol.94, issue.8, pp.1903-1916, 2008.
DOI : 10.1182/blood-2004-04-1667

M. Kleinschek, K. Boniface, S. Sadekova, J. Grein, E. Murphy et al., Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation, The Journal of Experimental Medicine, vol.156, issue.3, pp.525-534, 2009.
DOI : 10.1172/JCI108719

A. Postlethwaite, M. Holness, H. Katai, and R. Raghow, Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4., Journal of Clinical Investigation, vol.90, issue.4, pp.1479-1485, 1992.
DOI : 10.1172/JCI116015

C. Scaletti, A. Vultaggio, S. Bonifacio, L. Emmi, F. Torricelli et al., Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens, Arthritis & Rheumatism, vol.37, issue.2, pp.445-450, 2002.
DOI : 10.1002/art.10049

Y. Parel, M. Aurrand-lions, A. Scheja, J. Dayer, E. Roosnek et al., Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis, Arthritis & Rheumatism, vol.46, issue.10, pp.3459-3467, 2007.
DOI : 10.1002/art.22927

S. Atamas, V. Yurovsky, R. Wise, F. Wigley, G. Robinson et al., Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis, Arthritis & Rheumatism, vol.8, issue.6, pp.1168-1178, 1999.
DOI : 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L

A. Pernis, Th17 cells in rheumatoid arthritis and systemic lupus erythematosus, Journal of Internal Medicine, vol.116, issue.Suppl. 3, pp.644-652, 2009.
DOI : 10.1111/j.1365-2796.2009.02099.x

K. Kurasawa, K. Hirose, H. Sano, H. Endo, H. Shinkai et al., Increased interleukin-17 production in patients with systemic sclerosis, Arthritis & Rheumatism, vol.162, issue.11, pp.2455-2463, 2000.
DOI : 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K

M. Murata, M. Fujimoto, T. Matsushita, Y. Hamaguchi, M. Hasegawa et al., Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?, Journal of Dermatological Science, vol.50, issue.3, pp.240-242, 2008.
DOI : 10.1016/j.jdermsci.2008.01.001

T. Radstake, L. Van-bon, J. Broen, A. Hussiani, R. Hesselstrand et al., The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF?? and IFN?? Distinguishes SSc Phenotypes, PLoS ONE, vol.4, issue.6, p.5903, 2009.
DOI : 10.1371/journal.pone.0005903.t003

E. Leroy, C. Black, R. Fleischmajer, S. Jablonska, T. Krieg et al., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol, vol.15, pp.202-205, 1988.

K. Scharffetter, M. Kulozik, W. Stolz, B. Lankat-buttgereit, A. Hatamochi et al., Localization of collagen ??1(I) gene expression during wound healing by in situ hybridization, Journal of Investigative Dermatology, vol.93, issue.3, pp.405-412, 1989.
DOI : 10.1016/0022-202X(89)90067-5

M. Hussein, H. Hassan, E. Hofny, M. Elkholy, N. Fatehy et al., Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1??, and tumour necrosis factor ?? in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis, Journal of Clinical Pathology, vol.58, issue.2, pp.178-184, 2005.
DOI : 10.1136/jcp.2004.019224

A. Giovannetti, E. Rosato, C. Renzi, A. Maselli, L. Gambardella et al., Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis, Clinical Immunology, vol.137, issue.1, pp.122-133, 2010.
DOI : 10.1016/j.clim.2010.06.004

W. Ouyang, S. Rutz, N. Crellin, P. Valdez, and S. Hymowitz, Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease, Annual Review of Immunology, vol.29, issue.1, pp.71-109, 2011.
DOI : 10.1146/annurev-immunol-031210-101312

T. Starner, C. Barker, H. Jia, Y. Kang, P. Mccray et al., CCL20 Is an Inducible Product of Human Airway Epithelia with Innate Immune Properties, American Journal of Respiratory Cell and Molecular Biology, vol.29, issue.5, pp.627-633, 2003.
DOI : 10.1165/rcmb.2002-0272OC

S. Eyerich, K. Eyerich, D. Pennino, T. Carbone, F. Nasorri et al., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling, Journal of Clinical Investigation, vol.119, pp.3573-3585, 2009.
DOI : 10.1172/JCI40202DS1

S. Kagami, H. Rizzo, J. Lee, Y. Koguchi, and A. Blauvelt, Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis, Journal of Investigative Dermatology, vol.130, issue.5, pp.1373-1383, 2010.
DOI : 10.1038/jid.2009.399

K. Nograles, L. Zaba, A. Shemer, J. Fuentes-duculan, I. Cardinale et al., IL-22???producing ???T22??? T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17???producing TH17 T cells, Journal of Allergy and Clinical Immunology, vol.123, issue.6, pp.1244-1252, 2009.
DOI : 10.1016/j.jaci.2009.03.041

G. Sonnenberg, M. Nair, T. Kirn, C. Zaph, L. Fouser et al., Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A, The Journal of Experimental Medicine, vol.118, issue.6, pp.1293-1305, 2010.
DOI : 10.1038/nm1720

P. Simonian, F. Wehrmann, C. Roark, W. Born, O. Brien et al., ???? T cells protect against lung fibrosis via IL-22, The Journal of Experimental Medicine, vol.154, issue.10, pp.2239-2253, 2010.
DOI : 10.1038/nm1720
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947077

F. Fossiez, O. Djossou, P. Chomarat, L. Flores-romo, S. Ait-yahia et al., T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, Journal of Experimental Medicine, vol.183, issue.6, pp.2593-2603, 1996.
DOI : 10.1084/jem.183.6.2593

M. Wilson, S. Madala, T. Ramalingam, B. Gochuico, I. Rosas et al., Bleomycin and IL-1?????mediated pulmonary fibrosis is IL-17A dependent, The Journal of Experimental Medicine, vol.279, issue.3, pp.535-552, 2010.
DOI : 10.4049/jimmunol.180.1.655
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839145

K. Venkatachalam, S. Mummidi, D. Cortez, S. Prabhu, A. Valente et al., Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts, AJP: Heart and Circulatory Physiology, vol.294, issue.5, pp.2078-2087, 2008.
DOI : 10.1152/ajpheart.01363.2007

A. Yoshizaki, K. Yanaba, Y. Iwata, K. Komura, A. Ogawa et al., Cell Adhesion Molecules Regulate Fibrotic Process via Th1/Th2/Th17 Cell Balance in a Bleomycin-Induced Scleroderma Model, The Journal of Immunology, vol.185, issue.4, pp.2502-2515, 2010.
DOI : 10.4049/jimmunol.0901778

A. Doreau, A. Belot, J. Bastid, B. Riche, M. Trescol-biemont et al., Interleukin 17 acts in synergy with B cell???activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus, Nature Immunology, vol.10, issue.7, pp.778-785, 2009.
DOI : 10.1038/ni.1741
URL : https://hal.archives-ouvertes.fr/hal-00539348

H. Shen, J. Goodall, H. Gaston, and J. , Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis, Arthritis & Rheumatism, vol.70, issue.6, pp.1647-1656, 2009.
DOI : 10.1002/art.24568

J. Yang, Y. Chu, X. Yang, D. Gao, L. Zhu et al., Th17 and natural Treg cell population dynamics in systemic lupus erythematosus, Arthritis & Rheumatism, vol.104, issue.5, pp.1472-1483, 2009.
DOI : 10.1002/art.24499